Literature DB >> 8180380

Identification of a critical regulatory site in the human interleukin-3 promoter by in vivo footprinting.

S Cameron1, D S Taylor, E C TePas, N A Speck, B Mathey-Prevot.   

Abstract

Interleukin-3 (IL-3) is involved in proliferation and differentiation of hematopoietic progenitor cells. Its expression is subject to precise, tissue-specific regulation, and has been studied extensively in the gibbon T-cell line MLA 144 by a combination of functional assays and DNA binding experiments. To extend these studies, the gibbon IL-3 promoter was cloned and in vivo footprinting of the gibbon and human IL-3 proximal promoters was performed. The gibbon IL-3 promoter was found to be highly homologous to its human counterpart and both promoters yielded identical in vivo footprints after induction of IL-3 synthesis. In particular, we observed specific protection of three guanines over a core sequence TGTGGTTT (IF-1IL3) that had not been recognized in previous studies. IF-1IL3 is not found in other cytokine promoters, but it is conserved in the IL-3 promoter of several species and is similar to a recurring motif in viral and T-cell-specific cellular enhancers. IF-1IL3 binds a specific complex in MLA 144 and Jurkat nuclear extracts in vitro, which shares the same specificity as the complex bound by the polyoma virus and T-cell receptor delta enhancers. Mutation of the three guanines in IF-1IL3 core sequence disrupts binding in vitro and abrogates the ability of the IL-3 promoter to mediate inducible expression in T cells. Although IF-1IL3 is necessary for IL-3 expression, it is not sufficient: a truncated IL-3 promoter with an intact IF-1IL3 site but no other activator sites is transcriptionally silent. These studies describe a new regulatory element within the IL-3 promoter that is essential for expression and conserved between species.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8180380

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  23 in total

1.  The human SWI/SNF complex associates with RUNX1 to control transcription of hematopoietic target genes.

Authors:  Rachit Bakshi; Mohammad Q Hassan; Jitesh Pratap; Jane B Lian; Martin A Montecino; Andre J van Wijnen; Janet L Stein; Anthony N Imbalzano; Gary S Stein
Journal:  J Cell Physiol       Date:  2010-11       Impact factor: 6.384

2.  Transcriptional activation of a retrovirus enhancer by CBF (AML1) requires a second factor: evidence for cooperativity with c-Myb.

Authors:  A L Zaiman; J Lenz
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

3.  CCAAT enhancer-binding protein (C/EBP) and AML1 (CBF alpha2) synergistically activate the macrophage colony-stimulating factor receptor promoter.

Authors:  D E Zhang; C J Hetherington; S Meyers; K L Rhoades; C J Larson; H M Chen; S W Hiebert; D G Tenen
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

4.  ETS-core binding factor: a common composite motif in antigen receptor gene enhancers.

Authors:  B Erman; M Cortes; B S Nikolajczyk; N A Speck; R Sen
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

5.  Synergistic up-regulation of the myeloid-specific promoter for the macrophage colony-stimulating factor receptor by AML1 and the t(8;21) fusion protein may contribute to leukemogenesis.

Authors:  K L Rhoades; C J Hetherington; J D Rowley; S W Hiebert; G Nucifora; D G Tenen; D E Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

6.  RUNX1 regulates site specificity of DNA demethylation by recruitment of DNA demethylation machineries in hematopoietic cells.

Authors:  Takahiro Suzuki; Yuri Shimizu; Erina Furuhata; Shiori Maeda; Mami Kishima; Hajime Nishimura; Saaya Enomoto; Yoshihide Hayashizaki; Harukazu Suzuki
Journal:  Blood Adv       Date:  2017-09-06

7.  Transcriptional activity of core binding factor-alpha (AML1) and beta subunits on murine leukemia virus enhancer cores.

Authors:  A L Zaiman; A F Lewis; B E Crute; N A Speck; J Lenz
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

8.  Core binding factor beta-smooth muscle myosin heavy chain chimeric protein involved in acute myeloid leukemia forms unusual nuclear rod-like structures in transformed NIH 3T3 cells.

Authors:  C Wijmenga; P E Gregory; A Hajra; E Schröck; T Ried; R Eils; P P Liu; F S Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

9.  Human granulocyte-macrophage colony-stimulating factor enhancer function is associated with cooperative interactions between AP-1 and NFATp/c.

Authors:  P N Cockerill; A G Bert; F Jenkins; G R Ryan; M F Shannon; M A Vadas
Journal:  Mol Cell Biol       Date:  1995-04       Impact factor: 4.272

10.  AML1/RUNX1 works as a negative regulator of c-Mpl in hematopoietic stem cells.

Authors:  Yusuke Satoh; Itaru Matsumura; Hirokazu Tanaka; Sachiko Ezoe; Kentaro Fukushima; Masahiro Tokunaga; Masato Yasumi; Hirohiko Shibayama; Masao Mizuki; Takumi Era; Tsukasa Okuda; Yuzuru Kanakura
Journal:  J Biol Chem       Date:  2008-08-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.